08.11.25 -- Outsourced, In-House, Or A Combo: An Agile Recruiting Strategy Fuels Growth In Pharmas And Biotechs

Observe as experts highlight innovative tools and strategies advancing the safety of gene editing therapies while addressing off-target effects, regulatory demands, and manufacturing efficiency.

In a collaborative outsourcing model, the sponsor maintains direct contact with functional leads, eliminating communication gaps and enabling faster, better-informed decision-making.

Examine how nanoplate-based digital PCR streamlines AAV titering, providing faster results and greater accuracy, advancing gene therapy development from the lab to the clinic.

Observe how to transform biopharma learning with a human-centered, AI-enhanced ecosystem that personalizes development, fosters engagement, and aligns training with real-world impact.

Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.

Discover the difference a dedicated, expert project management team can make in ensuring the success and smooth execution of your cell therapy programs.

This study aims to explore the kinetics of capsid formation and impurity profiles over time, offering insights that can inform future process improvements.

Specialized cell collection services depend on access to a large, diverse donor pool as well as robust donor screening and efficient collection practices.

Monitor assets in real-time, anticipate issues, and maintain optimal performance effortlessly by exploring a cloud-based asset monitoring platform that offers proactive support and rapid response from experts.

This validated 22-marker flow cytometry panel enables deep immune profiling to identify key biomarkers influencing ACT efficacy — optimizing cell therapy outcomes and improving patient responses.

The need for greater volumes of high-quality raw materials like plasmid DNA in the cell and gene therapy space has made pDNA standardization integral to streamlining the development process.

Low AAV productivity and lack of platform processes continue to be key challenges driving AAV production cost up. Explore a robust and scalable suspension manufacturing platform for AAV production.